Moderna Inc (NASDAQ: MRNA)

MRNA 182.35
0.87 (0.5%)

Date: Fri, Dec 2, 2022 Open: 178.50 High: 182.80 Low: 177.00

10 x 182.35 = 1823.5
x $182.35 =

MRNA Profile

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 24 mRNA development programs as of early 2021, with 13 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.


YouTube Symbol Surfing

Watch these videos to learn how Symbol Surfing can increase your trading and investing knowledge and results.